Year: 2024
Type: erratum
Abstract: in the NAS report.Overall, these data show: (1) a large gap between state-level recommendations for medical cannabis and the quality evidence to support them, and (2) the need for more randomized controlled trials using the products currently available in dispensaries.
DOI: 10.1159/000537825
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $990
OpenAlex ID: W4392023019
